FDA's Shift Toward ISO 13485:2016
Effective February 2, 2026, FDA 21 CFR Part 820 has been replaced by the Quality Management System Regulation (QMSR). QMSR is now a regulatory requirement for all medical device manufacturers operating in the United States. The FDA has also released a new Compliance Program Manual outlining how inspections will be conducted under this updated framework. QMSR incorporates ISO 13485:2016 by reference, meaning the standard is legally part of the regulation but not reproduced within it. Companies must either purchase ISO 13485:2016 or access it online each time they need to review the content. While ISO certification is not required by the FDA, being certified to ISO 13485:2016 can significantly streamline compliance and inspection readiness under QMSR.
Key Impacts of QMSR
- QMSR replaces 21 CFR Part 820
- Non-compliance may result in warning letters
- FDA clarifications not found in ISO 13485
- QMSR aligns with ISO 13485:2016
- QMSR emphasizes risk management
- Improved traceability is mandated
- FDA expects leadership accountability
- Companies must show transition planning
- Increased supplier controls